Global Transfection Technologies Market is valued approximately USD 721.25 million in 2019 and is anticipated to grow with a healthy growth rate of more than 9.40 % over the forecast period 2020-2027. Transfection is an enabler technology used for many cell -based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. The increasing advances in cell research and therapeutic delivery drives the market growth. In April, 2018 the Stem Cell Network (SCN) announced a funding of $4 million for innovative stem cell and regenerative medicine research that will help translate discoveries into better health and economic growth for Canadians. It will support a total of 24 goal-directed projects from across Canada that are moving research from lab bench to bedside in areas such as brain injury, muscular dystrophy and vision repair. Transfection is an approach to produce exogenous nucleic acids such as DNA, RNA or oligonucleotide into cells. Research in gene transfer is being performed in in vivo conditions for different therapeutic applications augmenting the market growth. Also, in 2017 as per the Defence Advanced Research Projects Agency (DARPA), the DARPA has announced to invest $65 million over the course of next four years till 2021 in order to make CRISPR Gene Editing Safer and to counter bioterrorism threats. Further, the increasing prevalence of cancer and increasing penetration of obesity rises the demand for transfection. Further Massive grants and funds by government and private organizations escalates the demand for these technologies. However, High cost and hazard of negative reaction impedes the growth of the market over the forecast period of 2020-2027.

The regional analysis of global Transfection Technologies market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the large base of biotechnology companies and research and academic institutes in the region along with swelling research programs. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly improving health care facilities would create lucrative growth prospects for the Transfection Technologies market across Asia-Pacific region.

Major market player included in this report are:
Life Technologies
Sigma Aldrich
Lonza
Promega
Qiagen
Bio-Rad
Roche
Polyplus Transfection
Mirius Bio
Maxcyte
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Lipofection
Calcium Phosphate
Electroporation
Nucleofection
Magnetofection
Gene Gun
Viral
By Types:
Gene Delivery
DNA Delivery
Protein Delivery
SiRNA Delivery

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018
Base year - 2019
Forecast period - 2020 to 2027

Target Audience of the Global Transfection Technologies Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors